Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Boston Scientific, Cleerly, Bunkerhill Health, Deepqure, Discure Technologies, Levee Medical, Lunit, Microlight3D, Optellum, Parse Biosciences, Spinal Stabilization Technologies, Volpara.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Shandon Diagnostics.
Boston Scientific Corp. agreed to acquire Sonivie Ltd., developer of a therapeutic intravascular ultrasound system for denervation to treat resistant hypertension, pulmonary hypertension and chronic obstructive pulmonary disease. On a 100% basis, the deal is valued at $600 million with $400 million up front and $200 million upon achievement of a regulatory milestone.
The rash of firings at agencies of the Department of Health and Human Services has provoked a Feb. 28 letter from Reps. Dianna DeGette (D-Colo.) and Frank Pallone (D-N.J.), blasting the dismissals and insinuating that the dismissals were politically motivated.
The U.S. Patent and Trademark Office has reversed a 2022 agency memorandum on discretionary denials of patent procedures, such as inter partes reviews.
Precision Neuroscience Inc. recently partnered with Beth Israel Deaconess Medical Center to test its brain computer interface, the Layer 7 Cortical Interface, during craniotomy procedures.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biomérieux, Namsa, Qiagen, Sterotaxis, Wuxi Apptec.
RSS
